Cost of Revenue of MARIZYME, INC. from 31 Dec 2012 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
MARIZYME, INC. quarterly and annual Cost of Revenue in USD history and change rate from 31 Dec 2012 to 31 Mar 2024.
  • MARIZYME, INC. Cost of Revenue for the quarter ending 31 Mar 2024 was $9,647, a 75% decline year-over-year.
  • MARIZYME, INC. Cost of Revenue for the twelve months ending 31 Mar 2024 was $158,480.
  • MARIZYME, INC. annual Cost of Revenue for 2023 was $188,108, a 246% increase from 2022.
  • MARIZYME, INC. annual Cost of Revenue for 2022 was $54,319, a 32% decline from 2021.
  • MARIZYME, INC. annual Cost of Revenue for 2021 was $80,354.
Source SEC data
View on sec.gov
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

MARIZYME, INC. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $158,480 $9,647 -$29,628 -75% 01 Jan 2024 31 Mar 2024 10-Q 28 May 2024 2024 Q1
Q4 2023 $188,108 $48,233 01 Oct 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
Q3 2023 $50,989 +$35,486 +229% 01 Jul 2023 30 Sep 2023 10-Q 05 Mar 2025 2024 Q3
Q2 2023 $49,611 +$38,586 +350% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $39,275 01 Jan 2023 31 Mar 2023 10-Q 28 May 2024 2024 Q1
Q3 2022 $15,503 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $11,025 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2023 Q2
Q3 2020 $25,714 +$25,714 01 Jul 2020 30 Sep 2020 10-Q/A 24 Nov 2020 2020 Q3
Q1 2020 $0 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $0 $0 +$16 01 Oct 2019 31 Dec 2019 10-K 15 Apr 2020 2019 FY
Q3 2019 $16 $0 -$542 -100% 01 Jul 2019 30 Sep 2019 10-Q/A 24 Nov 2020 2020 Q3
Q2 2019 $526 $0 -$19,548 -100% 01 Apr 2019 30 Jun 2019 10-Q 03 Jul 2019 2019 Q2
Q1 2019 $20,074 $0 $0 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $20,074 $16 -$52,024 -100% 01 Oct 2018 31 Dec 2018 10-K 15 Apr 2020 2019 FY
Q3 2018 $72,098 $542 -$21,540 -98% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $93,638 $19,548 +$17,845 +1048% 01 Apr 2018 30 Jun 2018 10-Q 03 Jul 2019 2019 Q2
Q1 2018 $75,793 $0 -$11,114 -100% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $86,907 $52,008 +$199,162 01 Oct 2017 31 Dec 2017 10-K 05 Mar 2019 2018 FY
Q3 2017 $112,255 $22,082 -$106,615 -83% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $5,640 $1,703 -$117,301 -99% 01 Apr 2017 30 Jun 2017 10-K/A 27 Jun 2018 2017 FY
Q1 2017 $111,661 $11,114 -$96,731 -90% 01 Jan 2017 31 Mar 2017 10-K/A 27 Jun 2018 2017 FY
Q4 2016 $208,392 $147,154 01 Oct 2016 31 Dec 2016 10-K/A 27 Jun 2018 2017 FY
Q3 2016 $128,697 01 Jul 2016 30 Sep 2016 10-K/A 27 Jun 2018 2017 FY
Q2 2016 $119,004 01 Apr 2016 30 Jun 2016 10-K/A 27 Jun 2018 2017 FY
Q1 2016 $107,845 01 Jan 2016 31 Mar 2016 10-K/A 27 Jun 2018 2017 FY

MARIZYME, INC. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $188,108 +$133,789 +246% 01 Jan 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
2022 $54,319 -$26,035 -32% 01 Jan 2022 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
2021 $80,354 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2019 $0 -$20,074 -100% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2020 2019 FY
2018 $20,074 -$66,833 -77% 01 Jan 2018 31 Dec 2018 10-K 15 Apr 2020 2019 FY
2017 $86,907 -$121,485 -58% 01 Jan 2017 31 Dec 2017 10-K 05 Mar 2019 2018 FY
2016 $208,392 -$21,956 -9.5% 01 Jan 2016 31 Dec 2016 10-K/A 27 Jun 2018 2017 FY
2015 $230,348 +$230,348 01 Jan 2015 31 Dec 2015 10-K/A 27 Jun 2018 2017 FY
2014 $0 $0 01 Jan 2014 31 Dec 2014 10-K/A 27 Jun 2018 2017 FY
2013 $0 $0 01 Jan 2013 31 Dec 2013 10-K/A 27 Jun 2018 2017 FY
2012 $0 01 Jan 2012 31 Dec 2012 10-K/A 27 Jun 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.